Methotrexate and Mounjaro: Can You Take Both? (October 2026)

01 · The core answer

Can you take Mounjaro with methotrexate?

You may be able to, but only after your prescriber has reviewed your full medicine list and, ideally, your specialist has agreed.

Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose. You are asked to tell your prescriber about everything you take.¹ Methotrexate is a medicine that needs careful specialist oversight, so that conversation matters more than usual.

Our guides on taking both together cover related ground. Our page on weight loss injections with methotrexate looks at the wider injectable category.

02 · What to decide

The two decisions you are actually facing

The first decision is whether weight loss treatment is appropriate for you at all, given the condition methotrexate treats. That is a clinical judgement. Some people with inflammatory or autoimmune conditions find weight is a concern, whether because of reduced movement, other medicines, or a long illness. Others have a health picture where adding a new medicine needs more thought. Neither situation is unusual, and neither is a reason to avoid asking.

The second decision is how to coordinate. Your methotrexate is prescribed and monitored by a specialist team or your GP under a shared-care arrangement. Mounjaro would be prescribed separately. The safest route is for each clinician to know about the other medicine. That means telling the specialist you are considering Mounjaro and telling our prescriber about methotrexate in the consultation. Do not leave either side guessing.

Practical rule: do not change, pause or restart methotrexate because of Mounjaro unless the team that prescribes it tells you to. Likewise, do not delay telling anyone that you are on it. If you cannot get an appointment quickly, you do not need to rush the start of weight loss treatment. Waiting a short while for a proper answer costs far less than a problem you could have avoided.

Questions about methotrexate dosing and monitoring belong to your rheumatology, dermatology or gastroenterology team, and your patient information leaflet. If you have been given sick-day guidance for methotrexate, keep following it and ask your team how it applies if you ever have a spell of being unwell while also on a weight loss injection.

When you are ready to see whether you qualify, the Mounjaro pen page starts a free consultation with no obligation, and our weight loss clinic explains the wider programme.

03 · What the evidence covers

Methotrexate and Mounjaro: what to know

What is established is the general behaviour of Mounjaro as a medicine. It is a weekly injection, and it affects how the stomach empties. The product information tells people to inform their prescriber about all other medicines they take, with particular attention to narrow-margin medicines, insulin and sulfonylureas.¹

When a medicine is not named, that does not mean it is automatically free of issues. A pharmacist or prescriber can check the full product information, your own history, your kidney and liver results held by your specialist, and the way you take your methotrexate.

You can read the manufacturer's patient information yourself. It is the document your prescriber will check, and it lists the side effects and cautions in plain language.¹³ Reading it before your consultation helps you ask sharper questions. Make a note of anything that seems to touch your condition, your other tablets, or your usual routine.

It is also worth separating two questions that often get blurred. One is whether the two medicines interact chemically. The other is whether the effects of one, such as how you feel after an injection, could complicate the management of the other. Both are legitimate, and both are for clinicians. If you want to see how we have approached the same worry for similar conditions, our page on hydroxychloroquine and Mounjaro follows the same honest approach.

Finally, be wary of anyone offering to supply a prescription medicine without a consultation or prescription. A proper pathway asks about your other medicines precisely because an answer like this one can only come from your full picture.

04 · Stomach emptying and tablets

Stomach emptying and oral medicines

Mounjaro slows how quickly the stomach empties, and that can change how quickly some oral medicines are absorbed. This is most relevant when you start treatment or increase the dose.¹

Tirzepatide is described as the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ The slower emptying is part of why people feel fuller sooner. It is a feature of how the medicine works, not a rare quirk.

Why might timing matter? An oral medicine travels through the stomach before it is absorbed further along. If the stomach releases its contents more slowly, the speed of absorption can shift. For many medicines this makes little practical difference. For some it can matter, which is why the product information asks you to tell your prescriber about everything you take, and singles out narrow-margin medicines such as warfarin.¹

Your specialist knows your dose pattern, whether it is taken as tablets or by injection, and what your blood results look like. They are the right person to say whether the change in absorption timing is a concern, or whether it is irrelevant for you.

Bring this question to the conversation: I am considering a weekly injection that slows stomach emptying; does that affect how I should take my current medicines, and do you want to monitor anything differently in the early weeks or after a dose increase? That wording gives the clinician exactly what they need.

Two practical points follow. First, the early weeks and each dose increase are the moments the product information highlights, so those are the moments to be most alert and to keep your clinicians informed. Second, never adjust the timing of your tablets on your own to compensate. If your specialist wants any change, they will tell you how to make it.

The same caution applies to other regular tablets. For some medicines, no adjustment is needed; the information states that no adjustment is needed for paracetamol, for example.¹ Insulin and sulfonylureas are different: doses may need reducing to avoid low blood sugar. The point is that each medicine has its own answer, and a blanket assumption in either direction is unsafe.

If you are curious how another long-term medicine is handled, see our page on lisinopril and Mounjaro, which sets out the same principle for a blood pressure tablet.

05 · What to tell your prescriber

What to tell your prescriber

Tell your prescriber everything you take, including methotrexate, in the consultation. The product information asks for exactly this, and a complete list is the single most useful thing you can bring.¹ Our consultation is free, short and carries no obligation, and a GPhC-registered prescriber reviews it. It is not a scoring script.

Prepare a short list before you start. Include every prescription medicine, with the name, form and how you take it. Add anything you buy over the counter, including vitamins, herbal products and supplements. Add the condition each medicine is for, and the name of the specialist or surgery that manages it. If you take folic acid or other supporting medicines alongside methotrexate, list those too, as part of the full picture.

Also describe how you take methotrexate in plain terms: tablets or injection, and whether it is taken on a set day. You do not need to quote doses from memory; you can read them off your repeat prescription or your treatment record. Accuracy matters more than speed here.

Be open about the rest of your health. Mention any other long-term conditions, previous reactions to medicines, pregnancy plans, and whether you take oral contraception. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Where the product information flags a point, it is worth knowing it applies to you.

Tell them, too, about your recent history: have you been unwell lately, had a recent illness, or had a change in your regular medicines? A prescriber who knows the whole picture can make a better call, and can decline to supply if the timing is wrong. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Do not hold information back for fear of being turned down. A decline is a safety outcome, not a penalty. A prescriber would much rather say not yet, speak to your specialist first, than approve something that could cause difficulty later.

After the order, keep the line open. Repeat orders re-check suitability, and there is no auto-shipping, so each time you reorder you can update us on changes such as a new medicine, a dose change from your specialist, or a new symptom. Ongoing monthly reviews, dose-titration and follow-up assessments are part of the aftercare from the prescribing team, with side-effect support available.

Finally, tell your specialist and GP that you have started. Our consultation does not replace their involvement. It adds to it, and a shared understanding across everyone treating you is the safest way to manage any long-term medicine alongside a new one. You may find our guide on taking Mounjaro if you are on methotrexate helpful for the wording of that conversation.

06 · Eligibility and NHS access

Eligibility, and NHS versus private access

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you take methotrexate, you may already be under a specialist team. That team can be a valuable route to the NHS conversation, because they know your history. Ask your GP or specialist whether you could be considered for NHS weight management, and what route applies where you live. NHS access to Wegovy runs through specialist weight-management services; ask your GP.

The medicine itself is licensed in the UK for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ It is a prescription-only medicine, used alongside a reduced-calorie diet and increased physical activity. That means it is supplied only after a consultation reviewed by a GPhC-registered prescriber.

Private treatment is a legitimate option when you meet the licensed criteria and prefer not to wait. It is not a shortcut around safety checks. The same questions about your medicines apply, and a prescriber can still say no.

If you are weighing NHS against private, think about timing and continuity. An NHS route may be slower but is delivered inside your existing care. A private route can start sooner, but it is your responsibility to keep your specialist informed. Neither is the wrong choice, as long as every clinician involved knows what you take.

Remember that being eligible on paper is not the same as being suitable. Your own history, other conditions and current medicines decide that. Our consultation reviews all of it, and we would rather you discuss the plan with your specialist than be surprised later.

07 · How Mounjaro works

How Mounjaro works, and what happens when you stop

Mounjaro is the brand name for tirzepatide, a weekly injectable prescription medicine made by Eli Lilly. It activates two natural gut-hormone receptors at once, which helps regulate appetite and slows how quickly the stomach empties.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

This dual action is what distinguishes Mounjaro from single-action medicines such as semaglutide (Wegovy and Ozempic). Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. If you have read about those medicines and methotrexate, do not assume the answer carries across automatically. Each medicine has its own product information, and your prescriber should check the one you are actually considering.

Why does the mechanism matter to someone on methotrexate? Because appetite and stomach emptying are the two effects most likely to change your day-to-day experience: how much you eat, when you feel full, and how your stomach feels after the injection. Those changes interact with everyday life, including when and how you take tablets, so they are worth discussing with your specialist before the first dose.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That matters for two reasons.

First, if your specialist advises you to stop Mounjaro because of a problem, its effects will fade gradually, not instantly. Tell your clinicians and report suspected side effects, and they will guide you through that period. Second, if you are planning around something such as a change in your methotrexate, the medicine's presence in your body continues for several weeks, so plan with that in mind. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Each pen is a multi-dose KwikPen. Once in use, it can be kept out of the fridge for up to 30 days (not above 30°C). Before first use, store pens at 2–8°C and keep them until the printed expiry date. Follow the pen's instructions for the injection itself; we include needles, sharps bin and injection guidance with every order.

08 · Realistic expectations

What results to realistically expect

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

As a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. Trial averages do not predict your own result, and you should not plan around that figure.

Weight loss with this medicine is gradual and depends on diet, activity, dose and consistency. Some people respond strongly; others lose less. A reasonable plan is to agree goals with your prescriber, review progress at your monthly check-ins, and adjust based on how you feel and what your specialist advises.

Also think about what you want weight loss to do for you. For some people with long-term conditions, the aim is comfort, mobility or general health, and those are personal goals your clinicians can help you define. The scales are only one measure. Keep your specialist in the loop about how your condition feels as your weight changes, because that information is useful to them.

Finally, remember that stopping does not fix things permanently. Weight management is long-term, and the plan for maintenance and for any eventual stop should be agreed with your prescriber from the start.

09 · Other medicines to declare

Other medicines to declare alongside methotrexate

Methotrexate is rarely the only medicine on someone's list, so the whole list matters. The product information asks you to tell your prescriber about everything you take, especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas, where doses may need reducing to avoid low blood sugar.¹

Many people with inflammatory or autoimmune conditions take several medicines together: a disease-modifying drug, a pain reliever, something for the stomach, supplements, perhaps a steroid. Each one is a question for your prescriber. For example, our page on carbimazole and Mounjaro shows how we handle a different long-term tablet, and the logic is identical: declare it, let the prescriber check it, and follow their advice.

Do not assume a medicine is harmless because it is sold without a prescription. Some herbal and over-the-counter products affect the stomach, kidneys or liver, which may matter to your specialist. Your pharmacist can check anything you plan to take. Low-cost supplements sold with dramatic weight-loss claims have no clinical oversight, and they are not a substitute for a reviewed, licensed medicine.

Contraception deserves a specific mention. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. If you take the pill, switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. If you are planning a pregnancy, tell both your specialist and our prescriber early. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Keep an up-to-date list on your phone. Update it whenever any clinician changes something. A list that is wrong or out of date is more dangerous than no list, because people trust it.

If you have questions about whether a particular tablet is affected, ask a pharmacist. They can look at the product information for each item and tell you plainly. If something unexpected happens after you start, report it. Suspected side effects can be reported through the MHRA Yellow Card scheme, and your prescriber can help you do that.⁷

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · How ordering works

How ordering works with us

EverydayMeds is a GPhC-registered UK online pharmacy (registration 9012878), and every Mounjaro order goes through the same path. Start with a free online consultation: a short health questionnaire, no charge and no obligation. Put methotrexate on it, along with every other medicine you take, so the prescriber has the full picture.

Next, a GPhC-registered prescriber reviews your answers. It is a real review, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. If the prescriber wants you to speak to your specialist first, that is a reasonable outcome, not a failure.

Once approved, your medicine is dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm. Delivery is free, next-day and tracked, using DPD in temperature-controlled, discreet packaging. Saturday delivery is £14.99. Mounjaro is supplied through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens, and all six doses are in stock.

Costs are straightforward. The consultation is free, and the price shown is the price paid, with no hidden fees.

Aftercare matters when you take other long-term medicines. Ongoing monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team, with side-effect support. Repeat orders re-check suitability, so you can tell us about any change in your methotrexate or other medicines at each step. Nothing ships automatically.

Support is available Monday to Friday during office hours by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413. The free GLPTrackr companion app, available on iOS and Android, helps you keep a record of doses and how you feel, which is a handy thing to show your specialist.

Dispensed prescription medicines cannot be returned except where faulty, damaged or the wrong item, so contact us within 3 days in those cases. When you are ready, begin on the Mounjaro pen page. If you want a specific single-pen option, see our single pen guide for people on methotrexate.